Fast Track 100

This London company arranges meetings between leaders in biopharmaceuticals to solve industry challenges and improve best practice in areas such as the manufacture and supply of drugs. Founded in 2009 by Simon Chalk, 58, Christelle Simpson- Platre, 50, Tony White, 57, Darren Whitman, 53, and Steve Jones, 53, it says it has signed up as clients 24 of the world’s 25 largest biopharma firms, including Bayer, GSK and AstraZeneca. Sales, which represent membership fees from more than 80 groups, hit £6.7m last year. The company sold a minority stake to the private equity firm Vespa Capital in June 2018 for an undisclosed sum. It has begun to expand into the cell and gene therapy industries.

This profile reflects the company at time of publication and does not reflect any changes that may have subsequently occurred. Fast Track and its sponsors do not endorse, guarantee or recommend investment in any of the companies.

Company details
ActivityBiopharmaceutical forum organiser
LocationCentral London
Annual sales rise over 3 years47.49%
Latest sales £000s*6,707

If applicable:

* supplied by company † annualised figure